BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 14700406)

  • 1. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia.
    Blot S; Vandewoude K; Hoste E; De Waele J; Kint K; Rosiers F; Vogelaers D; Colardyn F
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):912-5. PubMed ID: 14700406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients.
    Blot S; De Bacquer D; Hoste E; Depuydt P; Vandewoude K; De Waele J; Benoit D; De Schuijmer J; Colardyn F; Vogelaers D
    Infect Control Hosp Epidemiol; 2005 Apr; 26(4):352-6. PubMed ID: 15865270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study.
    Blot SI; Vandewoude KH; Colardyn FA
    Chest; 2003 Apr; 123(4):1208-13. PubMed ID: 12684313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality.
    Mylotte JM; Kahler L; McCann C
    Am J Infect Control; 2001 Feb; 29(1):13-9. PubMed ID: 11172313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients.
    Blot SI; Vandewoude KH; Colardyn FA
    Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):471-3. PubMed ID: 12111606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients.
    Girou E; Stephan F; Novara A; Safar M; Fagon JY
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1151-8. PubMed ID: 9563733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
    Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
    Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.
    Blot S; Vandewoude K; Colardyn F
    Intensive Care Med; 2003 Mar; 29(3):471-5. PubMed ID: 12577148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial pneumonia and mortality among patients in intensive care units.
    Fagon JY; Chastre J; Vuagnat A; Trouillet JL; Novara A; Gibert C
    JAMA; 1996 Mar; 275(11):866-9. PubMed ID: 8596225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure.
    Karvellas CJ; Pink F; McPhail M; Austin M; Auzinger G; Bernal W; Sizer E; Kutsogiannis DJ; Eltringham I; Wendon JA
    Crit Care Med; 2010 Jan; 38(1):121-6. PubMed ID: 19770744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study.
    Soufir L; Timsit JF; Mahe C; Carlet J; Regnier B; Chevret S
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):396-401. PubMed ID: 10395140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.
    Blot S; Depuydt P; Vogelaers D; Decruyenaere J; De Waele J; Hoste E; Peleman R; Claeys G; Verschraegen G; Colardyn F; Vandewoude K
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):575-9. PubMed ID: 16018434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Blot SI; Vandewoude KH; Hoste EA; Colardyn FA
    Arch Intern Med; 2002 Oct; 162(19):2229-35. PubMed ID: 12390067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa.
    Blot S; Vandewoude K; Hoste E; Colardyn F
    J Hosp Infect; 2003 Jan; 53(1):18-24. PubMed ID: 12495681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.